These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preparation and characterization of a highly soluble Aβ LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755 [TBL] [Abstract][Full Text] [Related]
3. Protein derivitization-expressed protein ligation. Mitchell SF; Lorsch JR Methods Enzymol; 2014; 536():95-108. PubMed ID: 24423270 [TBL] [Abstract][Full Text] [Related]
4. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104 [TBL] [Abstract][Full Text] [Related]
5. Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis. Long F; Cho W; Ishii Y Protein Expr Purif; 2011 Sep; 79(1):16-24. PubMed ID: 21640828 [TBL] [Abstract][Full Text] [Related]
6. An Efficient Method for the Expression and Purification of Aβ(M1-42). Yoo S; Zhang S; Kreutzer AG; Nowick JS Biochemistry; 2018 Jul; 57(26):3861-3866. PubMed ID: 29757632 [TBL] [Abstract][Full Text] [Related]
7. MMP-7 cleaves amyloid β fragment peptides and copper ion inhibits the degradation. Taniguchi M; Matsuura K; Nakamura R; Kojima A; Konishi M; Akizawa T Biometals; 2017 Oct; 30(5):797-807. PubMed ID: 28871443 [TBL] [Abstract][Full Text] [Related]
8. A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. Walsh DM; Thulin E; Minogue AM; Gustavsson N; Pang E; Teplow DB; Linse S FEBS J; 2009 Mar; 276(5):1266-81. PubMed ID: 19175671 [TBL] [Abstract][Full Text] [Related]
9. Recombinant amyloid beta-peptide production by coexpression with an affibody ligand. Macao B; Hoyer W; Sandberg A; Brorsson AC; Dobson CM; Härd T BMC Biotechnol; 2008 Oct; 8():82. PubMed ID: 18973685 [TBL] [Abstract][Full Text] [Related]
10. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry. Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261 [TBL] [Abstract][Full Text] [Related]
11. Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer's disease? Mezentsev YV; Medvedev AE; Kechko OI; Makarov AA; Ivanov AS; Mantsyzov AB; Kozin SA J Biomol Struct Dyn; 2016 Nov; 34(11):2317-26. PubMed ID: 26513486 [TBL] [Abstract][Full Text] [Related]
12. The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity. Ovchinnikova OY; Finder VH; Vodopivec I; Nitsch RM; Glockshuber R J Mol Biol; 2011 May; 408(4):780-91. PubMed ID: 21402079 [TBL] [Abstract][Full Text] [Related]
13. Intein-mediated rapid purification of recombinant human pituitary adenylate cyclase activating polypeptide. Yu RJ; Hong A; Dai Y; Gao Y Acta Biochim Biophys Sin (Shanghai); 2004 Nov; 36(11):759-66. PubMed ID: 15514850 [TBL] [Abstract][Full Text] [Related]
14. Direct evidence for self-propagation of different amyloid-β fibril conformations. Spirig T; Ovchinnikova O; Vagt T; Glockshuber R Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967 [TBL] [Abstract][Full Text] [Related]
15. An Efficient Method of Expression and Purification of Amyloid-Beta (Aβ Ghosh D; Wälti MA; Riek R Methods Mol Biol; 2023; 2551():41-51. PubMed ID: 36310195 [TBL] [Abstract][Full Text] [Related]
16. pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity. Sofola-Adesakin O; Khericha M; Snoeren I; Tsuda L; Partridge L Acta Neuropathol Commun; 2016 Oct; 4(1):109. PubMed ID: 27717375 [TBL] [Abstract][Full Text] [Related]
17. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ. Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948 [TBL] [Abstract][Full Text] [Related]
18. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease. Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704 [TBL] [Abstract][Full Text] [Related]
19. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains. Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307 [TBL] [Abstract][Full Text] [Related]
20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]